Patients with Pulmonary Metastases from Head and Neck Cancer Benefit from Pulmonary Metastasectomy, A Systematic Review

<i>Background and Objectives</i>: The incidence of distant metastases in patients with head and neck cancer (HNC) is approximately 10%. Pulmonary metastases are the most frequent distant location, with an incidence of 70–85%. The standard treatment options are chemo-, immuno- and radiotherapy. Despi...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Georg Schlachtenberger, Fabian Doerr, Hruy Menghesha, Patrick Lauinger, Philipp Wolber, Anton Sabashnikov, Aron-Frederik Popov, Sascha Macherey-Meyer, Gerardus Bennink, Jens P. Klussmann, Thorsten Wahlers, Khosro Hekmat, Mathias B. Heldwein
Formato:	Artigo
Idioma:	Inglês
Publicado em:	MDPI AG 2022-07-01
Colecção:	Medicina
Assuntos:	pulmonary metastasectomy lung metastases immunotherapy head and neck cancer metastatic head and neck cancer
Acesso em linha:	https://www.mdpi.com/1648-9144/58/8/1000
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!